MIR200C and acute lymphoblastic leukemia: Studies showed that MIR200C was expressed at significantly lower levels in children with relapsing ALL compared to those at primary diagnosis, i.e., the decreased expression of MIR200C can be considered as a prognostic factor for relapse in childhood ALL [26].